Yoshiya Yamada, MD
Enriched profileRadiation Oncologist; Co-Chief, Multi-Disciplinary Spine Tumor Service · Memorial Sloan Kettering Cancer Center
Yoshiya Yamada is Radiation Oncologist; Co-Chief, Multi-Disciplinary Spine Tumor Service at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 496 publications with 24,662 citations (h-index 76); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Radiation Oncology profiles in the FindMyKOL directory.
Data verified 25 Oct 2026
Overview
Updated 27 Oct 2026
Yoshiya, MD, is Radiation Oncologist at Memorial Sloan Kettering Cancer Center. The public record shows 496 publications with 24,662 citations (h-index 76), centered on Management of metastatic bone disease, Advanced Radiotherapy Techniques, Brain Metastases and Treatment. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 5 companies.
- Most recent indexed publication: 2026 · Neuro-oncology advances
- Top research focus: Management of metastatic bone disease
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 5 companies
Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 6 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 200.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 26 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine
Sponsor: Memorial Sloan Kettering Cancer Center
- A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Sponsor: Memorial Sloan Kettering Cancer Center
- Trial for Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
Updated 26 Oct 2026
5 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20252 payments
- icotec Medical Inc.Program year20252 payments
- icotec Medical Inc.Program year20249 payments
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Opioid Agonist100%Oxycodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 26 Oct 2026
105 congress contributions (2003–2026) across AACR, ASCO, ASTRO per OpenAlex. The most recent:
- Cerebrospinal fluid biomarker profiling in patients with non–small cell lung cancer and leptomeningeal disease.
ASCO Annual Meeting
ASCO2026Co-author - Impact of Pain Management Interventions and Radiation Therapy on Pain Control and Treatment Accuracy in Spine Radiation for Metastasis
ASTRO Annual Meeting
ASTRO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 26 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Linac-based stereotactic radiosurgery for brain metastases: Survival and salvage treatment in a contemporary cohort of 3893 patients.
Neuro-oncology advances
Article2026 - Genomics correlates of brain metastasis and progression in colorectal cancer.
Neuro-oncology
Article2025 - T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between Treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy.
AJNR. American journal of neuroradiology
Article2023
Most-cited works
by citation count (OpenAlex)- 01Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaArticle2,090 citations2012
- 02A Novel Classification System for Spinal Instability in Neoplastic DiseaseArticle1,278 citations2010
- 03The NOMS Framework: Approach to the Treatment of Spinal Metastatic TumorsArticle937 citations2013
- 04
- 05Reliability analysis of the epidural spinal cord compression scaleArticle738 citations2010
Network
Updated 26 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 26 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
synapse.mskcc.org/synapse/people/1970
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →synapse.mskcc.org ↗ - Other
mskcc.org/es/cancer-care/doctors/yoshiya-josh-yamada
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 26 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University of Alberta
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →amportal.astro.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Guy McKhann, MD
Emory University School of Medicine
Patrick Wen, MD
Dana-Farber Cancer Institute
Minesh Mehta, MD
Florida International University Herbert Wertheim College of Medicine
Timothy Cloughesy, MD
Ronald Reagan UCLA Medical Center